TITLE

Review: Individualized written action plans based on peak expiratory flow improve asthma health outcomes

AUTHOR(S)
Greenstone, Michael
PUB. DATE
September 2004
SOURCE
ACP Journal Club;Sep/Oct2004, Vol. 141 Issue 2, p52
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article investigates whether individualized written action plans for patients improve asthma health outcomes. Outcomes were analyzed according to variations in action plans: the number of action points, personal best or percentage predicted peak expiratory flow," traffic light" action plan (colors used to signal the continuation of usual treatment green, increasing treatment yellow, or the need to seek help urgently red), and use of inhaled corticosteroids and oral corticosteroids. In patients with asthma, individualized written action plans based on peak expiratory flow, 2 to 4 action points, and treatment instruction on the use of both inhaled and oral corticosteroids improve asthma health outcomes.
ACCESSION #
14590737

 

Related Articles

  • Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Van Steenis, M. N. A.; Driesenaar, J. A.; Bensing, J. M.; Van Hulten, R.; Souverein, P. C.; Van Dijk, L.; De Smet, P. A. G. M.; Van Dulmen, A. M. // Patient Preference & Adherence;2014, Vol. 8, p83 

    Background: Beliefs play a crucial role in medication adherence. Interestingly, the relationship between beliefs and adherence varies when different adherence measures are used. How adherence, in turn, is related to asthma symptoms is still unclear. Our aim was to investigate the relationship...

  • Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Koopmans, J. G.; Lulfer, R.; Jansen, H. M.; Van Der Zee, J. S. // Thorax;Apr2006, Vol. 61 Issue 4, p306 

    Background: Addition of the long acting β2 agonist salmeterol to inhaled corticosteroids leads to better symptomatic asthma control than increasing the dose of inhaled corticosteroids. However, little is known about the long term effects of adding salmeterol on the asthmatic inflammatory...

  • 'SIMPLES': a structured primary care approach to adults with difficult asthma. Ryan, Dermot; Murphy, Anna; Stallberg, Bjorn; Baxter, Noel; Heaney, Liam G. // Primary Care Respiratory Journal;Sep2013, Vol. 22 Issue 3, p365 

    The substantial majority of patients with asthma can expect minimal breakthrough symptoms on standard doses of inhaled corticosteroids with or without additional add-on therapies. SIMPLES is a structured primary care approach to the review of a person with uncontrolled asthma which encompasses...

  • Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. Zureik, Mahmoud; Neukirch, Catherine; Leynaert, Benedicte; Liard, Renata; Bousquet, Jean; Neukirch, Francoise // BMJ: British Medical Journal (International Edition);8/24/2002, Vol. 325 Issue 7361, p411 

    Abstract Objective: To assess whether the severity of asthma is associated with sensitisation to airborne moulds rather than to other seasonal or perennial allergens. Design: Multicentre epidemiological survey in 30 centres. Setting: European Community respiratory health survey. Participants:...

  • Considerations in the long-term management of asthma in ambulatory patients. Williams, Dennis M. // American Journal of Health-System Pharmacy;5/15/2006, Vol. 63 Issue 10, pS14 

    Purpose. The goals of treatment and drug therapies used for long-term asthma control, classification of the disease by severity, and treatment based on severity are reviewed, with an emphasis on recent controversies in treatment approach and safety concerns. Summary. Patient education and...

  • Doubling Steroids Does Not Stop Asthma Exacerbations. Walling, Anne D. // American Family Physician;9/15/2004, Vol. 70 Issue 6, p1161 

    Discusses the study "Doubling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations: Randomised Controlled Trial," by T. W. Harrison et al., published in the January 24, 2004 issue of the journal "The Lancet." Study subjects; Treatments given; Intepretation of the research findings.

  • Anti-Inflammatory Activities of α2-Agonists. Hanania, Nicola A.; Moore, Robert H. // Current Drug Targets - Inflammation & Allergy;Sep2004, Vol. 3 Issue 3, p271 

    Beta2-adrenergic agonists ( β2-agonists) play a pivotal role in the acute and chronic management of asthma. Their major action on the airways is the relaxation of smooth muscle cells. In addition to their bronchodilator properties, β2-agonists may have other effects through their...

  • Pharmacotherapy -- add-on therapies.  // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS37 

    The article focuses on the effectiveness regarding the use inhaled corticosteriods (ICS)and leukotriene receptor antagonists (LTRA)as add-on therapy in treating children with asthma. The effectiveness ICS has been compared with long-acting bronchodilators (LABA) such as salmenterol or...

  • Asthma tools for Northern Ireland.  // Practice Nurse;3/11/2005, Vol. 29 Issue 5, p9 

    Reports that practice nurses in Northern Ireland are to be sent tools for controlling asthma due to the increased hospital admission of patients with asthma. Information on the number of people with asthma as of March 2005; Components of the Be in Control pack tools for practice nurses; Role of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics